⌘K

Login Start Free

Home/Filings/4/0001358403-19-000023

4//SEC Filing

Smith Alan K. 4

Accession 0001358403-19-000023

CIK 0001358403other

View on SEC.gov Company Profile

Filed

Feb 4, 7:00 PM ET

Accepted

Feb 5, 4:11 PM ET

Size

5.5 KB

Accession

0001358403-19-000023

Insider Transaction Report

Form 4

Period: 2019-02-01

BELLICUM PHARMACEUTICALS, INCBLCM

EVP, Technical Oprations

Transactions

Award
Stock Option (right to buy)
2019-02-01+75,000→ 75,000 total
Exercise: $3.35Exp: 2029-01-31→ Common Stock (75,000 underlying)

Footnotes (1)

[F1]25% of the shares subject to the stock option vest and become exercisable on January 1, 2020, and the remaining shares subject to the stock option vest and become exercisable in 36 equal monthly installments thereafter.

Documents

1 file

4
wf-form4_154940108443579.xmlPrimary
FORM 4

Issuer

BELLICUM PHARMACEUTICALS, INC

CIK 0001358403

Entity typeother

Related Parties

1

filerCIK 0001705246

Filing Metadata

Form type: 4
Filed: Feb 4, 7:00 PM ET
Accepted: Feb 5, 4:11 PM ET
Size: 5.5 KB

View on SEC.gov